Wearables in Pharma & Biotech Market

The report "Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031" The wearables in pharma & biotech market is expected to reach USD 9.97 billion by 2031 from USD 3.98 billion in 2026, at a CAGR of 20.2%.

Browse 531 market data Tables and 54 Figures spread through 457 Pages and in-depth TOC on "Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/wearables-pharma-biotech-market-99537956.html

The market for wearables in pharma & biotech is being fueled by fundamental changes in the way healthcare is delivered and received, especially with the focus on continuous and real-world data generation in different areas of therapy. The prevalence of multimorbidity, where patients experience multiple chronic conditions at any given time, is further fueling the need for multi-parameter monitoring instead of single-disease monitoring. According to the World Health Organization, there is an increase in multimorbidity worldwide, especially in elderly patients. This has further necessitated the need for integrated monitoring of cardiovascular, metabolic, and respiratory parameters. To this end, there is evidence from the National Health Service suggesting that 1 in every 4 adults in England is currently experiencing two or more long-term conditions. This highlights the importance of continuous monitoring solutions that can be provided through wearables, which are capable of tracking complex health interactions in real-time. Additionally, the digitization of clinical research and healthcare is driving the increased use of wearables in pharmaceutical and biotechnology studies.

By therapeutic area, diabetes segment to register fastest growth during forecast period

The diabetes segment is anticipated to show the highest growth rate in the wearables in pharma & biotech market during the forecast period. This is mainly because of the high rate of growth in the global diabetes population and the need for constant monitoring. According to the International Diabetes Federation (IDF) update of 2024, there are 589 million adults worldwide with diabetes mellitus. The numbers are projected to rise to over 850 million adults worldwide by 2050. This clearly indicates that there is a high rate of growth in the global population with diabetes. In the US, there are over 38 million people with diabetes, and nearly 1 in 3 adults has prediabetes. This clearly indicates that there is a high population that needs to be monitored. The global health expenditure on diabetes exceeded USD 1 trillion in 2023.

By application, clinical trials segment held largest market share in 2025

The clinical trials segment accounted for the largest share of the wearables in pharma & biotech industry in 2025. This is due to the increased need for efficient, patient-centric, and high-data-content study designs. According to the US Food and Drug Administration, there is increased focus on digital health technologies, such as wearables, in supporting decentralized clinical trials. In 2023, the Tufts Center for the Study of Drug Development found that the average cost of developing a new drug is above USD 2.6 billion. This is encouraging pharma companies to use wearable-enabled monitoring in order to decrease the cost of clinical trials. According to Nature Medicine publications, there is an increased chance of collecting data as often as required by using wearable devices in comparison to conventional site-based methods of collecting endpoint data. All these factors are resulting in the dominance of the clinical trials segment in the wearables in pharma & biotech industry.

North America accounted for largest market share in 2025

North America accounted for the largest share of the global wearables in pharma & biotech market in 2025, given its high rate of adoption of connected health technologies and high integration of patient-generated data. According to PubMed Central research on wearables and health data, 44.5% of 23,974 respondents used wearables, and this rate was higher among younger people and people from urban and high-income areas. This suggests that there is a high consumer base that is generating continuous real-world health data for pharma and biotech use. North America is also benefiting from its high rate of innovation in wearables and other pharma and biotech technologies. For instance, there is significant funding and research support from institutions such as the National Institutes of Health and the National Science Foundation to support biosensors and other wearables and digital health technologies. Furthermore, there is reimbursement support for remote patient monitoring from the Centers for Medicare & Medicaid Services, which is further boosting the use of wearables and other integrated healthcare technologies in the region .

Don’t miss out on business opportunities in Wearables in Pharma & Biotech Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]